IRIS Accounts Production v26.1.10.61 11885403 Board of Directors 31.1.26 1.2.25 31.1.26 31.1.26 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. true true true false true true false false false false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118854032025-01-31118854032026-01-31118854032025-02-012026-01-31118854032024-01-31118854032024-02-012025-01-31118854032025-01-3111885403ns15:EnglandWales2025-02-012026-01-3111885403ns14:PoundSterling2025-02-012026-01-3111885403ns10:Director12025-02-012026-01-3111885403ns10:Consolidated2026-01-3111885403ns10:ConsolidatedGroupCompanyAccounts2025-02-012026-01-3111885403ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3111885403ns10:Consolidatedns10:MediumEntities2025-02-012026-01-3111885403ns10:Consolidatedns10:Audited2025-02-012026-01-3111885403ns10:Medium-sizedCompaniesRegimeForDirectorsReport2025-02-012026-01-3111885403ns10:Medium-sizedCompaniesRegimeForAccounts2025-02-012026-01-3111885403ns10:Consolidated2025-02-012026-01-3111885403ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2025-02-012026-01-3111885403ns10:Medium-sizedCompaniesRegimeForAccountsns10:Consolidated2025-02-012026-01-3111885403ns10:FullAccounts2025-02-012026-01-3111885403ns5:Subsidiary12025-02-012026-01-3111885403ns5:Subsidiary22025-02-012026-01-311188540312025-02-012026-01-3111885403ns10:OrdinaryShareClass12025-02-012026-01-3111885403ns10:Director22025-02-012026-01-3111885403ns10:Director32025-02-012026-01-3111885403ns10:Director42025-02-012026-01-3111885403ns10:Director52025-02-012026-01-3111885403ns10:CompanySecretary12025-02-012026-01-3111885403ns10:RegisteredOffice2025-02-012026-01-3111885403ns10:Consolidated2024-02-012025-01-3111885403ns5:CurrentFinancialInstruments2026-01-3111885403ns5:CurrentFinancialInstruments2025-01-3111885403ns5:Non-currentFinancialInstruments2026-01-3111885403ns5:Non-currentFinancialInstruments2025-01-3111885403ns5:ShareCapital2026-01-3111885403ns5:ShareCapital2025-01-3111885403ns5:SharePremium2026-01-3111885403ns5:SharePremium2025-01-3111885403ns5:CapitalRedemptionReserve2026-01-3111885403ns5:CapitalRedemptionReserve2025-01-3111885403ns5:RetainedEarningsAccumulatedLosses2026-01-3111885403ns5:RetainedEarningsAccumulatedLosses2025-01-3111885403ns5:ShareCapital2024-01-3111885403ns5:RetainedEarningsAccumulatedLosses2024-01-3111885403ns5:SharePremium2024-01-3111885403ns5:CapitalRedemptionReserve2024-01-3111885403ns5:ShareCapital2024-02-012025-01-3111885403ns5:SharePremium2024-02-012025-01-3111885403ns5:RetainedEarningsAccumulatedLosses2024-02-012025-01-3111885403ns5:CapitalRedemptionReserve2024-02-012025-01-3111885403ns5:RetainedEarningsAccumulatedLosses2025-02-012026-01-3111885403ns5:CapitalRedemptionReserve2025-02-012026-01-3111885403ns5:NetGoodwill2025-02-012026-01-3111885403ns5:OwnedOrFreeholdAssetsns5:LandBuildings2025-02-012026-01-3111885403ns5:FurnitureFittings2025-02-012026-01-3111885403ns5:MotorVehicles2025-02-012026-01-3111885403ns5:LandBuildings2025-01-3111885403ns5:FurnitureFittings2025-01-3111885403ns5:MotorVehicles2025-01-3111885403ns5:LandBuildings2025-02-012026-01-3111885403ns5:LandBuildings2026-01-3111885403ns5:FurnitureFittings2026-01-3111885403ns5:MotorVehicles2026-01-3111885403ns5:LandBuildings2025-01-3111885403ns5:FurnitureFittings2025-01-3111885403ns5:MotorVehicles2025-01-3111885403ns5:CostValuation2025-01-31118854031ns5:Subsidiary12025-02-012026-01-3111885403ns5:Subsidiary12026-01-3111885403ns5:Subsidiary12025-01-3111885403ns5:Subsidiary12024-02-012025-01-3111885403ns5:Subsidiary232025-02-012026-01-3111885403ns5:Subsidiary22026-01-3111885403ns5:Subsidiary22025-01-3111885403ns5:Subsidiary22024-02-012025-01-3111885403ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3111885403ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3111885403ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2026-01-3111885403ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-01-3111885403ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2026-01-3111885403ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-01-3111885403ns5:WithinOneYear2026-01-3111885403ns5:WithinOneYear2025-01-3111885403ns5:BetweenOneFiveYears2026-01-3111885403ns5:BetweenOneFiveYears2025-01-3111885403ns5:AllPeriods2026-01-3111885403ns5:AllPeriods2025-01-3111885403ns5:Secured2026-01-3111885403ns5:Secured2025-01-3111885403ns5:AcceleratedTaxDepreciationDeferredTax2026-01-3111885403ns5:AcceleratedTaxDepreciationDeferredTax2025-01-3111885403ns5:DeferredTaxation2025-01-3111885403ns5:DeferredTaxation2025-02-012026-01-3111885403ns5:DeferredTaxation2026-01-3111885403ns10:OrdinaryShareClass12026-01-3111885403ns5:RetainedEarningsAccumulatedLosses2025-01-3111885403ns5:SharePremium2025-01-3111885403ns5:CapitalRedemptionReserve2025-01-31
REGISTERED NUMBER: 11885403 (England and Wales)















UNITED HEALTH GROUP 2 LIMITED

GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2026






UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)






CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026




Page

Company Information 1

Group Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 4 to 6

Consolidated Income Statement 7

Consolidated Other Comprehensive Income 8

Consolidated Statement of Financial Position 9

Company Statement of Financial Position 10

Consolidated Statement of Changes in Equity 11

Company Statement of Changes in Equity 12

Consolidated Statement of Cash Flows 13

Notes to the Consolidated Statement of Cash Flows 14

Notes to the Consolidated Financial Statements 15 to 26


UNITED HEALTH GROUP 2 LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2026







DIRECTORS: P J Pearson
M T Cheriton-Metcalfe
S D Travers
B M Morrish
K Stevens


SECRETARY: J L Flintham


REGISTERED OFFICE: Unit J The Quays
Burton Waters
Lincoln
Lincolnshire
LN1 2XG


REGISTERED NUMBER: 11885403 (England and Wales)


SENIOR STATUTORY AUDITOR: Tara Bellamy FCA


AUDITORS: Duncan & Toplis Audit Limited, Statutory Auditor
4 Henley Way
Doddington Road
Lincoln
Lincolnshire
LN6 3QR


BANKERS: HSBC Bank Plc
221 High Street
Lincoln
Lincolnshire
LN1 1TS

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 JANUARY 2026

The directors present their strategic report of the company and the group for the year ended 31 January 2026.

REVIEW OF BUSINESS
The Group delivered a strong financial performance during the year ended 31 January 2026.

Turnover increased to £8.72 million from £6.10 million, representing growth of approximately 43%. Profit before taxation increased significantly to £3.16 million (2025: £1.29 million), while net assets increased to £8.62 million (2025: £6.27 million). These results reflect continued demand for the Group's specialist residential and educational services together with strong occupancy levels and operational efficiency improvements.

The Group generated operating profit of £3.42 million (2025: £1.60 million) and ended the year with cash balances of £6.36 million (2025: £0.30 million). The directors consider these results to be highly satisfactory and reflective of the strength of the underlying business model.

Key performance indicators

KPI 2026 2025
Revenue £8.72m £6.10m
Operating profit £3.42m £1.60m
Profit before tax £3.16m £1.29m
Net assets £8.62m £6.27m
Cash balances £6.36m £0.30m

Financial position

At the year end the Group had net assets of £8.62 million and cash balances of £6.36 million. The Group also successfully refinanced part of its banking facilities during the year, resulting in improved liquidity and a stronger current asset position. The directors believe the Group remains well positioned to support future growth opportunities and investment in its children's services and educational operations.

PRINCIPAL RISKS AND UNCERTAINTIES
The principal risks affecting the Group include:

-funding pressure within the care and education sectors;
-recruitment and retention of suitably qualified staff;
-regulatory compliance with Ofsted and other sector-specific requirements;
-inflationary pressures affecting employment and operating costs;
-changes in local authority commissioning arrangements.

The Group mitigates these risks through structured governance, regular financial monitoring, staff development programmes, quality assurance procedures and maintenance of strong relationships with commissioning authorities.

FUTURE DEVELOPMENT
The directors intend to continue growing the Group through organic development of existing services and investment in additional capacity where demand exists. The Group expects demand for specialist residential care and education services to remain strong and continues to evaluate opportunities to expand both service offerings and geographical coverage.

GOING CONCERN
The directors have reviewed budgets, forecasts and projected cash flows covering a period of at least twelve months from the date of approval of the financial statements. Having considered available banking facilities, trading performance and forecast cash generation, the directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on the going concern basis.

ON BEHALF OF THE BOARD:





P J Pearson - Director


21 August 2026

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 JANUARY 2026

The directors present their report with the financial statements of the company and the group for the year ended 31 January 2026.

PRINCIPAL ACTIVITY
The principal activity of the group in the year under review was that of the provision of residential, therapeutic and educational services for children with emotional and behavioural difficulties.

DIVIDENDS
No dividends will be distributed for the year ended 31 January 2026.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 February 2025 to the date of this report.

P J Pearson
M T Cheriton-Metcalfe
S D Travers
B M Morrish
K Stevens

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

ON BEHALF OF THE BOARD:





P J Pearson - Director


21 August 2026

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
UNITED HEALTH GROUP 2 LIMITED

Opinion
We have audited the financial statements of United Health Group 2 Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 January 2026 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Statement of Financial Position, Company Statement of Financial Position, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Statement of Cash Flows and Notes to the Consolidated Statement of Cash Flows, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 January 2026 and of the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
UNITED HEALTH GROUP 2 LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We have identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our general commercial experience, knowledge of the sector, a review of regulatory and legal correspondence and through discussions with Directors and other management obtained as part of the work required by auditing standards. We have also discussed with the Directors and other management the policies and procedures relating to compliance with laws and regulations. We communicated laws and regulations throughout the team and remained alert to any indications of non-compliance throughout the audit.

The potential impact of different laws and regulations varies considerably. Firstly, the company is subject to laws and regulations that directly impact the financial statements (for example financial reporting legislation) and we have assessed the extent of compliance with such laws as part of our financial statements audit. We evaluated management incentives and opportunities for fraudulent manipulation of the financial statements, (including risk of override of controls) and determined that the principal risks were related to management bias in accounting estimate and judgemental areas of the financial statements such as depreciation of tangible fixed asset, as well as the risk of inappropriate journal entries to increase reported profitability. Audit procedures performed by the engagement team included the identification and testing of material and unusual journal entries and challenging management on key accounting estimates, assumptions and judgements made in preparation of the financial statements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
UNITED HEALTH GROUP 2 LIMITED


Secondly, the company is subject to other laws and regulations where the consequence for non-compliance could have a material effect on the amounts or disclosures in the financial statements. We identified compliance with Ofsted regulations as most likely to have such an effect.

Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the Directors and other management and inspection. We inspected the latest Ofsted inspection reports from visits in the year for any instances of non-compliance and discussed with management the impact of the outcomes of these visits on operations of the children's homes. Through these procedures, if we became aware of any non-compliance, we considered the impact on the procedures performed on the related financial statement items.

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. The further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. As with any audit, there is a greater risk of non-detection of irregularities as these may involve collusion, intentional omissions of the override of internal controls.

We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Tara Bellamy FCA (Senior Statutory Auditor)
for and on behalf of Duncan & Toplis Audit Limited, Statutory Auditor
4 Henley Way
Doddington Road
Lincoln
Lincolnshire
LN6 3QR

24 August 2026

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

CONSOLIDATED INCOME STATEMENT
FOR THE YEAR ENDED 31 JANUARY 2026

2026 2025
as restated
Notes £    £   

TURNOVER 8,719,948 6,099,157

Cost of sales 3,461,494 2,845,626
GROSS PROFIT 5,258,454 3,253,531

Administrative expenses 1,937,701 1,680,784
3,320,753 1,572,747

Other operating income 97,747 23,667
OPERATING PROFIT 4 3,418,500 1,596,414


Interest payable and similar expenses 6 254,740 307,252
PROFIT BEFORE TAXATION 3,163,760 1,289,162

Tax on profit 7 815,207 282,853
PROFIT FOR THE FINANCIAL YEAR 2,348,553 1,006,309
Profit attributable to:
Owners of the parent 2,348,553 1,006,309

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

CONSOLIDATED OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 JANUARY 2026

2026 2025
as restated
Notes £    £   

PROFIT FOR THE YEAR 2,348,553 1,006,309


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 2,348,553
Prior year adjustment 1,119,602
TOTAL COMPREHENSIVE INCOME SINCE LAST
ANNUAL REPORT

2,125,911

Total comprehensive income attributable to:
Owners of the parent 2,348,553 2,125,911

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

CONSOLIDATED STATEMENT OF FINANCIAL POSITION
31 JANUARY 2026

2026 2025
as restated
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 10 - -
Tangible assets 11 8,256,793 7,332,401
Investments 12 - -
8,256,793 7,332,401

CURRENT ASSETS
Debtors 13 8,532,117 12,938,076
Cash at bank and in hand 6,359,292 300,553
14,891,409 13,238,629
CREDITORS
Amounts falling due within one year 14 10,409,432 14,254,856
NET CURRENT ASSETS/(LIABILITIES) 4,481,977 (1,016,227 )
TOTAL ASSETS LESS CURRENT LIABILITIES 12,738,770 6,316,174

CREDITORS
Amounts falling due after more than one year 15 (4,072,084 ) -

PROVISIONS FOR LIABILITIES 19 (49,457 ) (47,498 )
NET ASSETS 8,617,229 6,268,676

CAPITAL AND RESERVES
Called up share capital 20 48,130 48,130
Share premium 21 6,705 6,705
Capital redemption reserve 21 47,380 47,380
Retained earnings 21 8,515,014 6,166,461
SHAREHOLDERS' FUNDS 8,617,229 6,268,676

The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2026 and were signed on its behalf by:





P J Pearson - Director


UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

COMPANY STATEMENT OF FINANCIAL POSITION
31 JANUARY 2026

2026 2025
as restated
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 10 - -
Tangible assets 11 8,256,795 7,332,403
Investments 12 17,000 17,000
8,273,795 7,349,403

CURRENT ASSETS
Debtors 13 6,709,082 10,716,541
Cash at bank and in hand 3,537,349 101,784
10,246,431 10,818,325
CREDITORS
Amounts falling due within one year 14 13,531,485 16,974,730
NET CURRENT LIABILITIES (3,285,054 ) (6,156,405 )
TOTAL ASSETS LESS CURRENT LIABILITIES 4,988,741 1,192,998

CREDITORS
Amounts falling due after more than one year 15 (4,072,084 ) -

PROVISIONS FOR LIABILITIES 19 (49,457 ) (47,498 )
NET ASSETS 867,200 1,145,500

CAPITAL AND RESERVES
Called up share capital 20 48,130 48,130
Share premium 21 6,705 6,705
Capital redemption reserve 21 47,380 47,380
Retained earnings 21 764,985 1,043,285
SHAREHOLDERS' FUNDS 867,200 1,145,500

Company's loss for the financial year (278,300 ) (187,142 )

The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2026 and were signed on its behalf by:





P J Pearson - Director


UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2026

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 February 2024 47,380 4,040,550 - 47,380 4,135,310
Prior year adjustment - 1,119,602 - - 1,119,602
As restated 47,380 5,160,152 - 47,380 5,254,912

Changes in equity
Issue of share capital 750 - 6,705 - 7,455
Total comprehensive income - 1,006,309 - - 1,006,309
Balance at 31 January 2025 48,130 6,166,461 6,705 47,380 6,268,676

Changes in equity
Total comprehensive income - 2,348,553 - - 2,348,553
Balance at 31 January 2026 48,130 8,515,014 6,705 47,380 8,617,229

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2026

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 February 2024 47,380 1,230,427 - 47,380 1,325,187

Changes in equity
Issue of share capital 750 - 6,705 - 7,455
Total comprehensive income - (187,142 ) - - (187,142 )
Balance at 31 January 2025 48,130 1,043,285 6,705 47,380 1,145,500

Changes in equity
Total comprehensive income - (278,300 ) - - (278,300 )
Balance at 31 January 2026 48,130 764,985 6,705 47,380 867,200

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 JANUARY 2026

2026 2025
as restated
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 8,160,613 2,515,744
Interest paid (254,740 ) (305,708 )
Tax paid (274,888 ) (455,583 )
Net cash from operating activities 7,630,985 1,754,453

Cash flows from investing activities
Purchase of tangible fixed assets (1,108,146 ) (303,593 )
Sale of intangible fixed assets - (1,119,602 )
Sale of tangible fixed assets - 4,588
Grant income 97,747 -
Net cash from investing activities (1,010,399 ) (1,418,607 )

Cash flows from financing activities
New loans in year 4,360,000 -
Loan repayments in year (4,093,501 ) (399,477 )
Amount introduced by directors 23,539 41,795
Amount withdrawn by directors (851,885 ) (5,419 )
Share issue - 750
Share premium - 6,705
Net cash from financing activities (561,847 ) (355,646 )

Increase/(decrease) in cash and cash equivalents 6,058,739 (19,800 )
Cash and cash equivalents at beginning of year 2 300,553 320,353

Cash and cash equivalents at end of year 2 6,359,292 300,553

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 JANUARY 2026

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2026 2025
as restated
£    £   
Profit before taxation 3,163,760 1,289,162
Depreciation charges 183,754 179,855
Profit on disposal of fixed assets - (1,244 )
Amortisation - 866,105
Government grants (97,747 ) -
Finance costs 254,740 307,252
3,504,507 2,641,130
Decrease/(increase) in trade and other debtors 2,675,273 (714,334 )
Increase in trade and other creditors 1,980,833 588,948
Cash generated from operations 8,160,613 2,515,744

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Statement of Cash Flows in respect of cash and cash equivalents are in respect of these Statement of Financial Position amounts:

Year ended 31 January 2026
31.1.26 1.2.25
£    £   
Cash and cash equivalents 6,359,292 300,553
Year ended 31 January 2025
31.1.25 1.2.24
as restated
£    £   
Cash and cash equivalents 300,553 320,353


3. ANALYSIS OF CHANGES IN NET (DEBT)/FUNDS

At 1.2.25 Cash flow At 31.1.26
£    £    £   
Net cash
Cash at bank and in hand 300,553 6,058,739 6,359,292
300,553 6,058,739 6,359,292
Debt
Debts falling due within 1 year (4,073,501 ) 3,805,585 (267,916 )
Debts falling due after 1 year - (4,072,084 ) (4,072,084 )
(4,073,501 ) (266,499 ) (4,340,000 )
Total (3,772,948 ) 5,792,240 2,019,292

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

1. STATUTORY INFORMATION

United Health Group 2 Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Basis of consolidation
The group financial statements consolidate the financial statements of United Health Group 2 Limited and the entities it controls (its subsidiaries) drawn up to 31 January each year. Control comprises the power to govern the financial and operating policies of the investee via control of the issued share capital of those companies.

Subsidiaries are consolidated from the date of their acquisition, being the date on which the group obtains control, and continue to be consolidated until the date that such control ceases.

The financial statements of subsidiaries are prepared for the same reporting year as the parent company, using consistent accounting policies.

Subsidiaries acquired during the year are consolidated under the acquisition method of accounting, whereby underlying assets and liabilities, and the consideration paid, are recorded at their fair values. The deficit of the fair value of consideration paid less than the fair value of net assets acquired is presented as negative consolidation goodwill.

Intercompany balances and transactions, including unrealised profits arising from intragroup transactions, have been eliminated.

Significant judgements and estimates
In the application of the group's accounting policies, management is required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis and are covered within the accounting policies:

(i) The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. See note 10 for the carrying amount of the property plant and equipment, and accounting policy note for the usual economic lives of each class of assets.

(ii) The group makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management considers factors including the current credit rating of the debtor, ageing profile of debtors and historical experience. See note 12 for the net carrying amount of the debtors and associated impairment provision.

(iii) The group has an obligation to pay pension benefits to certain employees. The cost of these benefits and the present value of the obligation depend on a number of factors, including; life expectancy, salary increases, asset valuations and the discount rate on corporate bonds. Management estimates these factors in determining the net pension obligation in the statement of financial position. The assumptions reflect historical experience and current trends. See note 3 for the disclosures relating to the defined contribution pension scheme.

Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects.

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

2. ACCOUNTING POLICIES - continued

Changes in accounting estimate
During the year ended 31 January 2026, United Education Services Limited changed its method used for recognising revenue. Previously, annual fee income was recognised evenly over the three academic terms. The revised method recognises annual fee income based on the number of academic days in each term. The revised methodology reflects more faithfully the pattern in which educational services are delivered and consumed throughout the academic year.

The directors consider this to be a change in accounting estimate under UK GAAP and, accordingly, the change has been applied prospectively in the current and future periods.

Had the revised method been applied in the prior year, profit for the year would have increased by £55,384.

Turnover
Turnover is measured at the fair value of the consideration received or receivable.The policies adopted for the recognition of turnover are as follows:

Rendering of services

When the outcome of a transaction can be estimated reliably, turnover is recognised in the period in which the services are provided and comprises residents' fees, educational fees and other ancillary services. Educational fees are measured net of VAT, all other fees are gross.

Where the outcome cannot be measured reliably, turnover is recognised only to the extent of the expenses recognised that are recoverable.

Goodwill
Negative goodwill arising on consolidation has been capitalised and released over a period of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Fixtures and fittings - 20% on cost
Motor vehicles - 25% on cost

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purpose of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, as estimate is made of the recoverable amount of the cash- generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that included the asset and generates cash inflows that largely independent of the cash inflows from other assets or group assets.

Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received using the accrual model.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The group operates defined contribution pension schemes. Contributions are recognised as an expense in the period in which they become payable. The group has no further payment obligations once contributions have been paid.

Leasing commitments
Lease payments are recognised as an expense over the lease term on a straight-line basis.

Financial instruments
The group has chosen to adopt the Sections 11 and 12 of FRS 102 in respect of financial instruments.

Basic financial assets, including trade and other debtors and cash and bank balances are initially recognised at transaction price, unless the arrangement constitute a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in the income statement.

Basic financial liabilities, including trade and other creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.

3. EMPLOYEES AND DIRECTORS
2026 2025
as restated
£    £   
Wages and salaries 3,185,268 2,612,600
Social security costs 390,705 262,014
Other pension costs 86,705 70,203
3,662,678 2,944,817

The average number of employees during the year was as follows:
2026 2025
as restated

Head office 13 12
Children's services 34 34
Education services 44 32
91 78

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

3. EMPLOYEES AND DIRECTORS - continued

2026 2025
as restated
£    £   
Directors' remuneration 401,124 368,433
Directors' pension contributions to money purchase schemes 15,698 15,596

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 5 5

Information regarding the highest paid director is as follows:
2026 2025
as restated
£    £   
Emoluments etc 111,500 116,000
Pension contributions to money purchase schemes 3,963 3,963

4. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2026 2025
as restated
£    £   
Other operating leases 19,733 17,175
Depreciation - owned assets 183,754 179,856
Profit on disposal of fixed assets - (1,244 )
Goodwill amortisation - (253,494 )
Auditors' remuneration 24,590 28,544

5. EXCEPTIONAL ITEMS
2026 2025
as restated
£    £   
Exceptional items - (10,000 )

The exceptional item is in relation to an intercompany loan write off due to the company being dissolved.

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2026 2025
as restated
£    £   
Bank interest 253,129 305,708
HMRC interest 1,611 1,544
254,740 307,252

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2026 2025
as restated
£    £   
Current tax:
UK corporation tax 813,248 286,069

Deferred tax 1,959 (3,216 )
Tax on profit 815,207 282,853

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2026 2025
as restated
£    £   
Profit before tax 3,163,760 1,289,162
Profit multiplied by the standard rate of corporation tax in the UK of 25 % (2025 -
25 %)

790,940

322,291

Effects of:
Expenses not deductible for tax purposes 608 2,932
Income not taxable for tax purposes (328 ) -
Capital allowances in excess of depreciation - (39,154 )
Depreciation in excess of capital allowances 22,028 -
Deferred tax 1,959 (3,216 )
Total tax charge 815,207 282,853

8. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


9. PRIOR YEAR ADJUSTMENT

During the year, the directors reviewed the accounting treatment of negative goodwill recognised on a previous business combination. The balance had previously been amortised over a period of ten years.

Following this review, it was concluded that the previous treatment did not accurately reflect the economic life of the underlying assets that resulted in this negative goodwill . A prior year adjustment has therefore been made to fully write down the remaining balance of the negative goodwill, with the comparative figures restated accordingly.

As a result of these adjustments, total fixed assets and opening reserves have increased by £1,119,602. This adjustment has no impact on the profit/loss in the current period.

This adjustment brings the financial statements into line with the requirements of FRS 102 in respect of the accounting treatment of negative goodwill.

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

10. INTANGIBLE FIXED ASSETS

Group
Goodwill
£   
COST
At 1 February 2025
and 31 January 2026 (1,415,342 )
AMORTISATION
At 1 February 2025
and 31 January 2026 (1,415,342 )
NET BOOK VALUE
At 31 January 2026 -
At 31 January 2025 -

Negative goodwilll arose on the purchase of United Children's Services Limited due to the net assets acquired being in excess of the consideration given.

11. TANGIBLE FIXED ASSETS

Group
Fixtures
Freehold and Motor
property fittings vehicles Totals
£    £    £    £   
COST
At 1 February 2025 7,477,388 941,920 213,728 8,633,036
Additions 1,022,846 45,035 40,265 1,108,146
At 31 January 2026 8,500,234 986,955 253,993 9,741,182
DEPRECIATION
At 1 February 2025 270,725 849,176 180,734 1,300,635
Charge for year 103,037 54,253 26,464 183,754
At 31 January 2026 373,762 903,429 207,198 1,484,389
NET BOOK VALUE
At 31 January 2026 8,126,472 83,526 46,795 8,256,793
At 31 January 2025 7,206,663 92,744 32,994 7,332,401

Included in cost of land and buildings is freehold land of £2,075,000 (2025 - £2,075,000) which is not depreciated.

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

11. TANGIBLE FIXED ASSETS - continued

Company
Fixtures
Freehold and Motor
property fittings vehicles Totals
£    £    £    £   
COST
At 1 February 2025 7,477,389 324,703 89,351 7,891,443
Additions 1,022,846 45,035 40,265 1,108,146
At 31 January 2026 8,500,235 369,738 129,616 8,999,589
DEPRECIATION
At 1 February 2025 270,725 231,960 56,355 559,040
Charge for year 103,037 54,253 26,464 183,754
At 31 January 2026 373,762 286,213 82,819 742,794
NET BOOK VALUE
At 31 January 2026 8,126,473 83,525 46,797 8,256,795
At 31 January 2025 7,206,664 92,743 32,996 7,332,403

Included in cost of land and buildings is freehold land of £ 2,075,000 (2025 - £ 2,075,000 ) which is not depreciated.

12. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 February 2025
and 31 January 2026 17,000
NET BOOK VALUE
At 31 January 2026 17,000
At 31 January 2025 17,000

The group or the company's investments at the Statement of Financial Position date in the share capital of companies include the following:

Subsidiaries

United Children's Services Limited
Registered office: Unit J The Quays, Burton Waters, Lincoln, LN1 2XG
Nature of business: Children's therapeutic and educational services
%
Class of shares: holding
Ordinary 100.00
2026 2025
£    £   
Aggregate capital and reserves 1,575,402 1,167,638
Profit for the year 1,507,764 697,385

United Children's Services Limited owns 100% of the share capital of United Education Services Limited.

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

12. FIXED ASSET INVESTMENTS - continued

United Education Services Limited
Registered office: Unit J The Quays, Burton Waters, Lincoln, LN1 2XG
Nature of business: The provision of educational services
%
Class of shares: holding
Ordinary 100.00
2026 2025
£    £   
Aggregate capital and reserves 6,191,631 3,972,541
Profit for the year 2,719,090 1,642,571


13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2026 2025 2026 2025
as restated as restated
£    £    £    £   
Trade debtors 2,288,544 1,817,140 - -
Amounts owed by group undertakings - - 540,902 558,415
Other debtors 6,132,294 11,103,654 6,131,677 10,151,586
VAT - - 23,507 -
Prepayments and accrued income 111,279 17,282 12,996 6,540
8,532,117 12,938,076 6,709,082 10,716,541

Amounts owed from group undertakings are unsecured, interest free and repayable on demand.

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2026 2025 2026 2025
as restated as restated
£    £    £    £   
Bank loans and overdrafts (see note 16) 267,916 4,073,501 267,916 4,073,501
Trade creditors 91,906 113,368 2,503 2,079
Amounts owed to group undertakings - - 5,755,982 4,531,292
Taxation 669,248 130,888 - -
Other taxes and social security 90,603 61,641 28,042 18,277
VAT 592,564 270,541 - -
Other creditors 353,663 342,296 155,521 200,250
Directors' current accounts 7,314,212 8,142,558 7,311,125 8,139,471
Accruals and deferred income 1,029,320 1,120,063 10,396 9,860
10,409,432 14,254,856 13,531,485 16,974,730

Amounts owed to group undertakings are unsecured, interest free and repayable on demand.

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group Company
2026 2025 2026 2025
as restated as restated
£    £    £    £   
Bank loans (see note 16) 4,072,084 - 4,072,084 -

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

16. LOANS

An analysis of the maturity of loans is given below:

Group Company
2026 2025 2026 2025
as restated as restated
£    £    £    £   
Amounts falling due within one year or on demand:
Bank loans 267,916 4,073,501 267,916 4,073,501
Amounts falling due between one and two years:
Bank loans - 1-2 years 364,042 - 364,042 -
Amounts falling due between two and five years:
Bank loans - 2-5 years 3,708,042 - 3,708,042 -

17. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Non-cancellable
operating leases
2026 2025
as restated
£    £   
Within one year - 18,000
Between one and five years - 3,000
- 21,000

Company
Non-cancellable
operating leases
2026 2025
as restated
£    £   
Within one year - 18,000
Between one and five years - 3,000
- 21,000

18. SECURED DEBTS

The following secured debts are included within creditors:

Group Company
2026 2025 2026 2025
as restated as restated
£    £    £    £   
Bank loans 4,340,000 4,073,501 4,340,000 4,073,501

HSBC UK Bank Plc holds a fixed and floating charge over all the assets of the parent and one of the subsidiaries.

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

19. PROVISIONS FOR LIABILITIES

Group Company
2026 2025 2026 2025
as restated as restated
£    £    £    £   
Deferred tax
Accelerated capital allowances 49,457 47,498 49,457 47,498

Group
Deferred
tax
£   
Balance at 1 February 2025 47,498
Charge to Income Statement during year 1,959
Balance at 31 January 2026 49,457

Company
Deferred
tax
£   
Balance at 1 February 2025 47,498
Charge to Income Statement during year 1,959
Balance at 31 January 2026 49,457

20. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: as restated
£    £   
96,260 Ordinary £0.50 48,130 48,130

21. RESERVES

Group
Capital
Retained Share redemption
earnings premium reserve Totals
£    £    £    £   

At 1 February 2025 6,166,461 6,705 47,380 6,220,546
Profit for the year 2,348,553 2,348,553
At 31 January 2026 8,515,014 6,705 47,380 8,569,099

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

21. RESERVES - continued

Company
Capital
Retained Share redemption
earnings premium reserve Totals
£    £    £    £   

At 1 February 2025 1,043,285 6,705 47,380 1,097,370
Deficit for the year (278,300 ) (278,300 )
At 31 January 2026 764,985 6,705 47,380 819,070

Retained earnings
Includes all current and prior period retained profits and losses less dividends paid. All amounts are distributable.

Capital redemption reserve
This reserve arose on the purchase of the parent's own Ordinary B shares.

Share premium
This reserve arose on the purchase of additional shares for above market value.

22. PENSION COMMITMENTS

Assets of the group's pension scheme are held separately in an independently administered fund. At the financial reporting date the group had pension commitments of £17,305 (2025 - £11,090).

23. CONTINGENT LIABILITIES

The group is a party to a composite cross guarantee given to the HSBC Bank Plc between Manor Homes (Yorkshire) Limited, United Children's Services Limited, United Education Services Limited, United Health Group 2 Limited and Manor Homes Property Company Limited.

24. RELATED PARTY DISCLOSURES

Key management personnel of the entity or its parent (in the aggregate)
2026 2025
as restated
£    £   
Amount due to related party 7,426,792 8,303,151

Other related parties
2026 2025
as restated
£    £   
Amount due from related party 6,132,294 11,103,654

During the year, a total of key management personnel compensation of £ 481,657 (2025 - £ 434,029 ) was paid.

25. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is P J Pearson.

UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

26. SHARE-BASED PAYMENT TRANSACTIONS

The company has a share option scheme for key employees. Options are exercisable at a price equal to the average market price of the company's shares on the date of grant.

2024 Options

The vesting period is 5 years, options can be exercised when the exercise conditions have been met, which require the company to hit a certain level of EBITDA. The exercise of the options is also dependent on eligible executives remaining in employment over the vesting period.

If an individual ceases to be an employee for any reason, the board may permit them to exercise all or any part of the option. If the board does not make such a decision after 90 days after the termination of the employment, the option will lapse.